FDA
approval
· 2016-05-20
FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)
Summary
The FDA approved a supplemental application for VIVITROL (naltrexone) by Alkermes, Inc. This action represents a supplemental approval related to the product's …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VIVITROL (NALTREXONE)